
Oncology Clinical Evidence Brief Builder
Build physician-ready oncology clinical evidence briefs in minutes
What You Can Do
You can synthesize complex oncology clinical evidence, patient population insights, and competitive context into structured one-page briefs designed for pre-call preparation. Each brief arms you with specific clinical endpoints, superiority data, patient segmentation, anticipated objections with clinical counter-arguments, payer barriers, and measurable call objectives—ensuring high-confidence, compliant physician conversations.
Features
Extracts and structures primary/secondary endpoints with statistical significance vs. standard-of-care
Maps appropriate patient populations, inclusion/exclusion criteria, and ideal use cases
Anticipates physician concerns and provides evidence-backed clinical counter-arguments
Contextualizes your product within the competitive landscape with differentiation points
Identifies key payer barriers and cost-effectiveness justifications
Defines meeting goals, success metrics, and logical conversation flow
Ensures all claims are grounded in clinical data with appropriate source citations
Example Output
Example 1: Early-Stage Lung Cancer Positioning
Clinical Evidence Brief: Therapy X in First-Line NSCLC
- Primary Endpoint: 18-month PFS improvement of 6.2 months vs. standard chemotherapy (HR 0.64, p<0.001)
- Target Population: PD-L1 ≥50%, Stage IIIB-IV, ECOG 0-1, no brain metastases
- Anticipated Objection: "What about toxicity?"
- Counter: Grade 3+ adverse events 28% vs. 32% with standard therapy; discontinuation rate lower by 4%
- Payer Barrier: Cost per QALY
- Solution: $145K QALY at median 2.1-year OS improvement; aligned with ICER threshold
- Call Objective: Understand current patient flow; identify 3-5 eligible patients for Q1 discussion
Example 2: Reactivation Brief for Low-Volume Prescriber
Key data points: Recent Phase 3 data showing 40% response rate in resistant population; payer pre-authorization streamlined; nursing support program reduces administration burden by 20%.
What's Included
- SKILL.md: Full skill instruction file with usage guidelines and compliance frameworks
- Clinical Evidence Brief Template: One-page structured outline (clinical data, populations, objections, payer barriers, call objectives)
- Objection Reference Checklist: Common oncology physician objections with evidence-based response frameworks
- Competitive Context Worksheet: Structured comparison matrix (efficacy, safety, cost, access)
- Payer Reimbursement Checklist: Key value drivers, formulary tiers, and access barriers by major payers
Who It's For
- Oncology Pharma Sales Representatives — preparing for physician calls and account planning
- Oncology Medical Science Liaisons — supporting field teams with clinical evidence synthesis
- Pharma Market Access Managers — preparing payer value arguments and competitive positioning
- Oncology Product Managers — briefing sales teams on clinical differentiation and positioning
- Hospital/Specialty Pharmacy Directors — evaluating formulary positioning and clinical evidence
Best For
- Pre-call preparation briefs for scheduled physician meetings
- Reactivation strategies for low-volume or competitive-vulnerable accounts
- New indication or patient population launch preparation
- Multi-stakeholder meeting preparation (oncologist, pharmacist, payer liaison)
- Competitive response and defensive positioning briefs
- Payer value-based argument development







